IPP Bureau
GSK and Fleming Initiative launch bold new fight against antimicrobial resistance
By IPP Bureau - November 21, 2025
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
GSK teams up with LTZ Therapeutics to launch next-generation cancer therapies
By IPP Bureau - November 21, 2025
The collaboration to develop breakthrough myeloid cell engagers (MCEs) signals a bold push into a promising new frontier in cancer therapy
Merck KGaA fires up new supercomputer to turbocharge scientific breakthroughs
By IPP Bureau - November 21, 2025
Exemplifies commitment of Merck to energy efficiency and sustainable practices in high-performance computing by featuring advanced water-cooling systems and a hybrid cloud infrastructure
Alkem launches globally acclaimed De Simone Probiotic in India, expands GI portfolio
By IPP Bureau - November 21, 2025
The formulation is backed by over 80 clinical trials and 200 scientific publications
Mankind Pharma inks licencing pact with Actimed to bring cachexia treatments to South Asia
By IPP Bureau - November 21, 2025
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
Kiran Mazumdar-Shaw ranked 2nd most generous woman by Hurun India
By IPP Bureau - November 21, 2025
The 2025 edition of the EdelGive Hurun list recognizes 24 exceptional women leaders for their philanthropic impact across critical areas
SOMA and Aura partner to advance innovation in on-press color correction
By IPP Bureau - November 21, 2025
SOMA Color Mind is designed to simplify and accelerate color setup directly on the printing press
Piramal Pharma Solutions’ UK facility bags updated MHRA GMP certification
By IPP Bureau - November 21, 2025
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
Innovent Biologics’ experimental weight-loss drug achieves breakthrough in Phase 3 trial
By IPP Bureau - November 21, 2025
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
EMA launches streamlined process to fast-track critical medicines, vaccines
By IPP Bureau - November 21, 2025
The move is expected to be crucial during health crises
.png "in-cosmetics Asia 2025 smashes records, draws global beauty elite")
in-cosmetics Asia 2025 smashes records, draws global beauty elite
By IPP Bureau - November 21, 2025
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Thyrocare launches comprehensive GLP-1 health check across India
By IPP Bureau - November 21, 2025
Glucagon-Like Peptide-1 is a natural hormone that regulates blood sugar, controls appetite, and slows digestion
FDA nod to Koselugo for adults with Rare NF1 tumors, expanding life-changing treatment
By IPP Bureau - November 21, 2025
Teva launches 'Teva Rise' to harness global innovation and transform healthcare
By IPP Bureau - November 21, 2025
The initiative aims to connect startups and tech companies with its business units,
